Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Short term Debt (2020 - 2023)

Historic Short term Debt for Zevra Therapeutics (ZVRA) over the last 3 years, with Q4 2023 value amounting to $37.7 million.

  • Zevra Therapeutics' Short term Debt changed N/A to $37.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was $37.7 million, marking a year-over-year change of. This contributed to the annual value of $37.7 million for FY2023, which is N/A changed from last year.
  • Per Zevra Therapeutics' latest filing, its Short term Debt stood at $37.7 million for Q4 2023.
  • Zevra Therapeutics' 5-year Short term Debt high stood at $37.7 million for Q4 2023, and its period low was $390000.0 during Q4 2020.
  • In the last 3 years, Zevra Therapeutics' Short term Debt had a median value of $683000.0 in 2021 and averaged $12.9 million.